1. Home
  2. BBIO vs TAL Comparison

BBIO vs TAL Comparison

Compare BBIO & TAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • TAL
  • Stock Information
  • Founded
  • BBIO 2015
  • TAL 2003
  • Country
  • BBIO United States
  • TAL China
  • Employees
  • BBIO N/A
  • TAL N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • TAL Other Consumer Services
  • Sector
  • BBIO Health Care
  • TAL Real Estate
  • Exchange
  • BBIO Nasdaq
  • TAL Nasdaq
  • Market Cap
  • BBIO 6.7B
  • TAL 5.9B
  • IPO Year
  • BBIO 2019
  • TAL 2010
  • Fundamental
  • Price
  • BBIO $34.17
  • TAL $9.42
  • Analyst Decision
  • BBIO Strong Buy
  • TAL Buy
  • Analyst Count
  • BBIO 12
  • TAL 4
  • Target Price
  • BBIO $57.09
  • TAL $13.12
  • AVG Volume (30 Days)
  • BBIO 3.1M
  • TAL 9.7M
  • Earning Date
  • BBIO 04-29-2025
  • TAL 04-24-2025
  • Dividend Yield
  • BBIO N/A
  • TAL N/A
  • EPS Growth
  • BBIO N/A
  • TAL N/A
  • EPS
  • BBIO N/A
  • TAL 0.14
  • Revenue
  • BBIO $127,415,000.00
  • TAL $2,250,233,000.00
  • Revenue This Year
  • BBIO $13.67
  • TAL $35.85
  • Revenue Next Year
  • BBIO $118.02
  • TAL $25.61
  • P/E Ratio
  • BBIO N/A
  • TAL $69.35
  • Revenue Growth
  • BBIO N/A
  • TAL 50.98
  • 52 Week Low
  • BBIO $21.62
  • TAL $7.35
  • 52 Week High
  • BBIO $39.47
  • TAL $15.30
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 44.19
  • TAL 41.64
  • Support Level
  • BBIO $33.92
  • TAL $9.04
  • Resistance Level
  • BBIO $39.16
  • TAL $9.35
  • Average True Range (ATR)
  • BBIO 1.50
  • TAL 0.44
  • MACD
  • BBIO -0.24
  • TAL 0.14
  • Stochastic Oscillator
  • BBIO 10.35
  • TAL 26.99

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About TAL TAL Education Group

TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions, and the like. Among those business lines, TAL focuses on enrichment learning and content solutions.

Share on Social Networks: